Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
Klodjan Stafa, Elpida Tsika, Roger Moser, et al.
Human Molecular Genetics (2013) Vol. 23, Iss. 8, pp. 2055-2077
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Jin‐Sung Park, Ryan L. Davis, Carolyn M. Sue
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 5
Open Access | Times Cited: 492
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Brent J. Ryan, Selim Hoek, Edward A. Fon, et al.
Trends in Biochemical Sciences (2015) Vol. 40, Iss. 4, pp. 200-210
Open Access | Times Cited: 489
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
Shirley Yin-Yu Pang, Philip Wing‐Lok Ho, Huifang Liu, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 306
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
Mei Yue, Kelly M. Hinkle, Paul Davies, et al.
Neurobiology of Disease (2015) Vol. 78, pp. 172-195
Open Access | Times Cited: 232
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
Sandra Franco-Iborra, Miquel Vila, Céline Perier
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 172
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 74
Key genes and convergent pathogenic mechanisms in Parkinson disease
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 26
Genetics and genomics of Parkinson’s disease
Michelle K. Lin, Matthew J. Farrer
Genome Medicine (2014) Vol. 6, Iss. 6
Open Access | Times Cited: 170
LRRK2 pathobiology in Parkinson's disease
Ian Martin, Jungwoo Wren Kim, Valina L. Dawson, et al.
Journal of Neurochemistry (2014) Vol. 131, Iss. 5, pp. 554-565
Open Access | Times Cited: 152
Cellular processes associated with LRRK2 function and dysfunction
Rebecca L. Wallings, Claudia Manzoni, Rina Bandopadhyay
FEBS Journal (2015) Vol. 282, Iss. 15, pp. 2806-2826
Open Access | Times Cited: 151
LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson’s disease
Fiona Bonello, Sidi-Mohamed Hassoun, François Mouton‐Liger, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 10, pp. 1645-1660
Open Access | Times Cited: 133
Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
Amin Karimi-Moghadam, Saeid Charsouei, Benjamin Bell, et al.
Cellular and Molecular Neurobiology (2018) Vol. 38, Iss. 6, pp. 1153-1178
Open Access | Times Cited: 124
The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis
Michael Huang, Shannon Chiang, Danuta S. Kalinowski, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-26
Open Access | Times Cited: 121
LRRK2 and mitochondria: Recent advances and current views
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 110
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne Beccano-Kelly, Naila Kuhlmann, Igor Tatarnikov, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 109
SIRT3 and mitochondrial metabolism in neurodegenerative diseases
Illari Salvatori, Cristiana Valle, Alberto Ferri, et al.
Neurochemistry International (2017) Vol. 109, pp. 184-192
Closed Access | Times Cited: 98
Targeting mitophagy in Parkinson's disease
Emily H. Clark, Aurelio Vázquez de la Torre, Tamaki Hoshikawa, et al.
Journal of Biological Chemistry (2020) Vol. 296, pp. 100209-100209
Open Access | Times Cited: 94
Target Engagement in Lead Generation
Timothy B. Durham, Marı́a-Jesús Blanco
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 5, pp. 998-1008
Open Access | Times Cited: 92
Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer’s Disease
P. Hemachandra Reddy, Maria Mańczak, Xiangling Yin
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 1, pp. 147-162
Open Access | Times Cited: 92
Current perspective of mitochondrial biology in Parkinson's disease
Navneet Ammal Kaidery, Bobby Thomas
Neurochemistry International (2018) Vol. 117, pp. 91-113
Open Access | Times Cited: 84
Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
Anamaria Jurcău
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11847-11847
Open Access | Times Cited: 84
LRRK2 and the Endolysosomal System in Parkinson’s Disease
Madalynn L. Erb, Darren J. Moore
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1271-1291
Open Access | Times Cited: 81
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top